| Literature DB >> 33737520 |
Tracy Coelho1,2, Eva Sonnenberg-Riethmacher3,4, Yifang Gao5,6, Enrico Mossotto1, Alisher Khojanazarov3, Annie Griffin5, Saida Mukanova3, Aiymkul Ashimkhanova3, Rachel Haggarty7, Anton Borissenko3, James J Ashton1,2, Imogen S Stafford1, Akshay Batra2, Nadeem A Afzal2, Michael P Stanton8, Bhumita Vadgama9, Kapura Adrisova10, Robert M Beattie2, Anthony P Williams5, Sarah Ennis1, Dieter Riethmacher11,12.
Abstract
The precise role of periostin, an extra-cellular matrix protein, in inflammatory bowel disease (IBD) is unclear. Here, we investigated periostin in paediatric IBD including its relationship with disease activity, clinical outcomes, genomic variation and expression in the colonic tissue. Plasma periostin was analysed using ELISA in 144 paediatric patients and 38 controls. Plasma levels were assessed against validated disease activity indices in IBD and clinical outcomes. An immuno-fluorescence for periostin and detailed isoform-expression analysis in the colonic tissue was performed in 23 individuals. We integrated a whole-gene based burden metric 'GenePy' to assess the impact of variation in POSTN and 23 other genes functionally connected to periostin. We found that plasma periostin levels were significantly increased during remission compared to active Crohn's disease. The immuno-fluorescence analysis demonstrated enhanced peri-cryptal ring patterns in patients compared to controls, present throughout inflamed, as well as macroscopically non-inflamed colonic tissue. Interestingly, the pattern of isoforms remained unchanged during bowel inflammation compared to healthy controls. In addition to its role during the inflammatory processes in IBD, periostin may have an additional prominent role in mucosal repair. Additional studies will be necessary to understand its role in the pathogenesis, repair and fibrosis in IBD.Entities:
Year: 2021 PMID: 33737520 DOI: 10.1038/s41598-021-85096-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379